| abstract |
The present invention relates to pharmaceutical compositions which are caused by fungi and yeast and which are useful for treating skin diseases accompanied by inflammation and associated with bacterial infections. Such compositions may comprise a therapeutically effective amount of sertaconazole, or a pharmaceutically acceptable salt, solvent compound, isomer thereof, or mixture thereof; A therapeutically effective amount of hydrocortisone, a pharmaceutically acceptable ester of hydrocortisone, at least one compound selected from the group consisting of antibacterial quinoline compounds or compositions thereof. |